PharmaTimes - December 2021

With Christmas just around the corner, it is only natural to reflect on the changes and trends of 2021 as we move closer to the new year. WInter is always challenging for the healthcare sector and this year it is particularly so, due to winter pressures coupled with the ongoing issues associated with COVID-19. However, there is still much to celebrate and reflect on as we head into 2022, and much to read in our latest issue.

EMIG’s Leslie Galloway takes a look at the key developments across the UK life sciences sector, offering an in-depth look at the notable barriers to access that remain as well as other changes including the NICE Methods and Process Review.

Maddy Farnworth examines how the pandemic has brought into sharp focus the importance of long-term sustainability and resilience of health systems. In her article, she considers three interconnected areas where the pharma industry needs to focus its attention to demonstrate its continued commitment to working for good.

OVID Health’s Jenny Ousbey also considers how sustainability has taken the spotlight in 2021 for the healthcare communications industry, with 2022 shaping up to be an important year for the sector to demonstrate its commitment to progress.

We also celebrate the winners of Clinical Researcher of the Year – The Americas 2021, with the exceptional talent of clinical researchers across the Americas having been recognised during a live virtual awards ceremony on 28 October.

The International Clinical Researcher of the Year 2022 competition is now open for entry!

December 2021 - magazine highlights

Patient file: Duchenne muscular dystrophy

PharmaTimes talks to Filippo Buccella, whose son Luca was...

Behavioural science: a new ally for Medical Affairs

Ben Routley and Mark Pringle take a look at how behavioura...

Parkinson’s disease and gene therapy: strategic and operational considerations

The gene therapy era can be said to have begun in 1990, wh...

The ever-increasing importance of the patient’s voice

We are currently witnessing a significant shift in healthc...

Sustainability is the word

If there was a word to sum up healthcare communications in...

Pharmaceuticals in 2022

The pharma industry has been pivotal during the pandemic a...

Maintaining the halo effect

What’s next for the pharmaceutical industry?

The UK life sciences sector: 2021 review

A look at the key developments across the sector this year

Why pharma needs to understand population health

Often misunderstood, the new focus on prevention and popul...

Inclusion zone

Nothing crystallises the need for diversity and inclusion...